CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema...
Phase 2
Charlotte, North Carolina, United States and 35 other locations
This study will evaluate the safety, tolerability, and efficacy of ANB032 in subjects with moderate to severe atopic dermatitis (AD).
Phase 2
Charlotte, North Carolina, United States and 79 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Shelby, North Carolina, United States of America and 558 other locations
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Phase 3
Charlotte, North Carolina, United States of America and 320 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Charlotte, North Carolina, United States of America and 487 other locations
The primary objectives of this study are to:* estimate vaccine response in rocatinlimab group vs placebo group, assessed using antibody anti-tetanus...
Phase 3
Matthews, North Carolina, United States and 84 other locations
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.
Phase 3
Charlotte, North Carolina, United States and 201 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Phase 3
Shelby, North Carolina, United States and 342 other locations
Clinical trials
Research sites
Resources
Legal